Vascular Dementia

If any of the terms on this page are unclear or you want to learn more about them click here!

Vascular dementia is cognitive decline caused mainly by disease or injury involving the blood vessels of the brain. It can develop after a major stroke, after several smaller strokes, or gradually as disease of the brain’s smallest blood vessels damages white matter and disconnects neural networks. Because the cause and pattern of injury vary so much, vascular dementia is not one single disease with one characteristic presentation.

Researchers increasingly use the broader term vascular cognitive impairment (VCI) to describe the full spectrum. VCI can range from subtle changes that do not prevent independent living to major impairment that qualifies as dementia. The phrase vascular contributions to cognitive impairment and dementia (VCID) is also used to emphasize that vascular injury often contributes to cognitive decline even when it is not the only pathology present.

Symptoms depend on which brain regions and connections are affected. Slowed thinking, difficulty planning or switching between tasks, poor attention, and reduced problem-solving are especially common. Memory loss can occur, but it may be less prominent early than in Alzheimer’s disease. Some people also develop changes in gait, balance, mood, motivation, speech, or bladder control. The course can be sudden and stepwise after strokes, but it can also be slow and gradual when small vessel disease accumulates over many years.

Learn more about vascular dementia.

Pathology

Vascular cognitive impairment can result from several forms of cerebrovascular injury. A large stroke may destroy enough tissue to impair cognition directly, particularly if it affects a strategically important region involved in memory, attention, language, or executive function. Multiple smaller strokes can create a broader pattern of disconnected networks even when no single stroke seems large enough to explain the full syndrome.

Cerebral small vessel disease is another major source of vascular cognitive decline. It affects the small arteries, arterioles, capillaries, and veins that supply deep brain tissue. On MRI, the resulting injury may appear as white matter hyperintensities, lacunes, microbleeds, or small areas of tissue loss. Many of these lesions can develop without an obvious clinical stroke, which is why cognitive decline may be gradual rather than stepwise.

White matter is especially important in vascular dementia. It contains bundles of axons that connect distant brain regions, allowing them to work as coordinated networks. Chronic blood-vessel dysfunction can damage myelin, oligodendrocytes, and axons, slowing communication between the frontal lobes and deeper brain structures. This network disconnection helps explain why processing speed, attention, planning, and gait are often affected together.

Biological Pathways

One central pathway is impaired blood flow and energy delivery. Neurons depend on a continuous supply of oxygen and glucose. When a vessel is blocked suddenly, energy failure can trigger excitotoxicity, calcium overload, oxidative stress, and cell death. When blood flow is reduced more subtly over time, cells may survive but function under chronic metabolic stress.

A second pathway is dysfunction of the neurovascular unit, the closely connected system made up of blood-vessel cells, support cells, and neurons. Healthy endothelial cells help regulate blood flow and maintain the blood-brain barrier. When these cells become dysfunctional, vessels may respond poorly to the brain’s changing energy needs and the barrier separating blood from brain tissue may become leaky.

Inflammation and oxidative stress can then reinforce the injury. Blood-brain barrier disruption allows proteins and immune signals from the circulation to influence brain tissue, while damaged cells activate microglia and other inflammatory responses. These processes can further injure small vessels, myelin, and axons.

Causes

Vascular dementia is caused by cerebrovascular disease, but many different conditions can produce that disease. These include ischemic stroke, hemorrhagic stroke, cerebral small vessel disease, narrowing or hardening of larger arteries, and heart conditions that send clots to the brain or reduce effective blood flow.

Many of the most important risk factors are the same ones that increase the risk of stroke and heart disease. High blood pressure is especially important, particularly when it is present in midlife. Diabetes, smoking, high cholesterol, atrial fibrillation, obesity, physical inactivity, and sleep apnea can also contribute. Age increases vulnerability, but vascular cognitive impairment is not an inevitable part of aging.

Progression

The progression of vascular dementia depends on the type of vascular injury. After a large or strategically placed stroke, cognitive changes may appear suddenly. Some function may improve during recovery as swelling decreases, surviving networks adapt, and rehabilitation helps the brain rebuild skills. A later stroke can then cause another abrupt decline, producing the classic “stepwise” pattern.

Small vessel disease often follows a quieter course. Processing speed, attention, gait, and executive function may worsen gradually as white matter injury accumulates. There may be no clear moment when the disease began, and the progression can look more like Alzheimer’s disease than the traditional picture of repeated strokes.

Mixed pathology makes the course even less predictable. Someone with both vascular injury and Alzheimer’s disease may show a steady decline with occasional sudden worsening after a stroke or medical illness. Depression, apathy, sleep problems, medication effects, and delirium can also worsen cognitive function without necessarily representing permanent progression.

Treatment Overview

There is currently no medication approved by the FDA specifically to reverse vascular dementia. The core treatment strategy is to prevent additional vascular injury and support the functions that remain. This makes identifying the cause of the vascular disease especially important.

Treatment may include management of blood pressure, diabetes, cholesterol, smoking, physical inactivity, or sleep apnea. Antiplatelet or anticoagulant medications may be used to prevent another stroke when appropriate for the underlying cause, but they are not general treatments for dementia and must be individualized because they also carry bleeding risks. Exercise, a heart-healthy diet, and treatment of cardiac disease support both vascular and brain health.

Some cognitive medications developed for Alzheimer’s disease, including cholinesterase inhibitors and memantine, have shown small benefits in some studies of vascular dementia and are used in certain countries or clinical situations. They are not approved specifically for vascular dementia in the United States, and benefit may be more likely when mixed Alzheimer’s pathology is also suspected.

Research Direction

One major research goal is improving how vascular brain injury is measured. Newer imaging methods aim to measure blood-brain barrier leakage, perfusion, vessel reactivity, and network disconnection earlier. Researchers are also developing blood and cerebrospinal fluid biomarkers that can distinguish vascular injury from Alzheimer’s, Lewy body, or other neurodegenerative pathologies. This matters because many older adults have more than one disease process.

A second major direction is moving beyond stroke prevention toward direct repair and protection. Potential strategies include improving endothelial function, stabilizing the blood-brain barrier, reducing damaging inflammation, supporting remyelination, and protecting white matter axons from degeneration. These approaches remain investigational, but they target the chronic biological aftermath of vascular disease rather than only the clot or risk factor that started it.

Sources

Wiesje M. van der Flier et al. (2018). “Vascular Cognitive Impairment.”
Joanna M. Wardlaw, Colin Smith, and Martin Dichgans. (2019). “Small Vessel Disease: Mechanisms and Clinical Implications.”
Vincent Chung Tong Mok, Yuan Cai, and Hugh S. Markus. (2024). “Vascular Cognitive Impairment and Dementia: Mechanisms, Treatment, and Future Directions.”
Farzaneh A. Sorond et al. (2026). “Vascular Contributions to Cognitive Impairment and Brain Health: Clinical Update and Mechanistic Considerations.”
Matthew J. Lennon and Perminder S. Sachdev. (2026). “Vascular Cognitive Impairment and Dementia: Prevention, Treatments, Mechanisms and Management Options for the Future.”
Perminder S. Sachdev et al. (2014). “Diagnostic Criteria for Vascular Cognitive Disorders: A VASCOG Statement.”